08:00 , Jan 7, 2013 |  BioCentury  |  Finance

Analyst tracks

Analyst tracks Mike King joined JMP Securities as managing director and senior equity research analyst. He was managing director and director of research at Dawson James Securities and, prior to that, managing director and senior...
07:00 , Oct 22, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/19 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Deutsche Bank Robyn Karnauskas Price target Buy 23% 19.6 Jefferies Eun Yang Price target Buy Karnauskas raised her...
07:00 , Sep 10, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/7 cls Addex Therapeutics Ltd. (SIX:ADXN) Wedbush Christopher Marai New Outperform 21% CHF9.20 Marai set a CHF28 target. He believes the "primary value driver"...
07:00 , Jul 30, 2012 |  BC Week In Review  |  Company News

Callisto, Synergy deal

Synergy will acquire its principal stockholder Callisto in a stock deal. The deal values Callisto at $117 million based on Synergy's close of $4.34 on July 20, before the deal was announced. Each Callisto common...
07:00 , Jul 30, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/27 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Deutsche Bank Robyn Karnauskas Price target Buy 10% $108.97 Jefferies Eun Yang Price target Hold Leerink Howard Liang...
07:00 , Jul 23, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/20 cls Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Piper Jaffray Edward Tenthoff Price target Neutral 0% $15.68 Tenthoff raised his target to $14 from $11.50 after...
07:00 , Jul 2, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/29 cls Arena Pharmaceuticals Inc. (NASDAQ:ARNA) BMO Capital Markets Jim Birchenough Price target Market perform 1% $9.98 Jefferies Thomas Wei Price target Buy Piper...
07:00 , Jun 25, 2012 |  BioCentury  |  Analyst Picks & Changes

Analyst picks and changes

Analyst picks and changes Company Bank Analyst Coverage Opinion Wk chg 6/22 cls Celgene Corp. (NASDAQ:CELG) Baird Christopher Raymond Price target Outperform -7% $61.63 Barclays Capital Ying Huang Price target Overweight Jefferies Thomas Wei Price...
07:00 , Jun 4, 2012 |  BC Week In Review  |  Financial News

Trovagene completes follow-on

Trovagene Inc. (NASDAQ: TROV), San Diego, Calif.   Business: Diagnostic   Date completed: 5/30/12   Type: Follow-on   Raised: $9.2 million   Units: 1.2 million   Price: $8 (unit)   Shares after offering: 13.8 million...
07:00 , May 28, 2012 |  BC Week In Review  |  Financial News

Trovagene amends follow-on

Trovagene Inc. (Pink:TROV), San Diego, Calif.   Business: Diagnostic   Date announced: 5/23/12   Type: Follow-on   To be raised: $20 million   Units: 2 million   Price: $9.90 (unit)   Underwriters: Aegis Capital; Summer...